טוען...
CA125 in Ovarian Cancer
Twenty five years after its discovery, circulating CA125 antigen is recommended for clinical use in the US for ovarian cancer (OC) screening of high risk women with ovaries despite its limited sensitivity and specificity. Recent findings suggest that CA125 might also serve as a predictive marker for...
שמור ב:
Main Authors: | , |
---|---|
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
2007
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2872496/ https://ncbi.nlm.nih.gov/pubmed/20477371 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/17520363.1.4.513 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|